DT insider files Form 144 to sell 90,000 shares via Charles Schwab
Rhea-AI Filing Summary
Dynatrace, Inc. (DT) notice files a Form 144 proposing to sell 90,000 common shares through The Charles Schwab Corporation with an approximate aggregate market value of $4,350,000. The filing reports 301,506,242 shares outstanding and lists the approximate sale date as 10/02/2025 on the NYSE.
The securities were reported as acquired from the issuer as RSU & PSU awards, with underlying grant dates between 11/18/2022 and 8/15/2024 and an acquisition/vesting/payment date of 06/05/2025. The filer reports no sales in the past three months in this notice.
Positive
- Brokered sale through a registered broker (The Charles Schwab Corporation) which supports orderly execution and compliance
- Acquisition via issuer awards (RSUs and PSUs) clearly documented with grant date range and vesting/payment date
Negative
- Large planned sale relative to typical insider trades: 90,000 shares valued at $4.35M could be perceived as insider liquidity
- No statement of reliance on a 10b5-1 trading plan or additional remarks in the filing to clarify timing or intent
Insights
TL;DR: Insider intends to sell vested equity awards: 90,000 DT shares valued at $4.35M, using a broker; no recent sales reported.
The filing is a routine Rule 144 notification indicating an intended sale of vested RSUs/PSUs. The use of a registered broker and the declaration of acquisition dates align with standard compliance for exempt resales. Absence of sales in the prior three months suggests this notice is for a first planned disposition following vesting. Investors should note the filing documents intent to sell but does not confirm execution or any trading plan date beyond the approximate sale date provided.
TL;DR: This is a procedural disclosure of award-derived shares slated for sale; it signals insider liquidity but not a governance event.
The report discloses that the securities originated from company-issued RSUs and PSUs across multiple grant dates, vesting and paid on 06/05/2025. Such disclosures are routine when insiders monetize vested compensation. The filing does not state reliance on a 10b5-1 plan or include remarks about material non-public information. On governance grounds, the filing meets disclosure norms but conveys limited substantive change to corporate control or strategy.